知っているようで知らない　新しい糖尿病網膜症診療

出版社： メジカルビュー社
著者：
発行日： 2016-09-20
分野： 臨床医学：外科  >  眼科学
ISBN： 9784758316255
電子書籍版： 2016-09-20 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

12,100 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

12,100 円(税込)

購入する

商品紹介

まずは糖尿病や糖尿病網膜症の病態（構造・機能）をミクロ，マクロから，やさしいイラストなどの表現でスイスイ理解。次に網膜症の所見をバリエーション豊かに載せ，目で見て正確に診断できるヒントが得られる。さらに治療方法は内科的アプローチと外科的アプローチを経験の少ない若手眼科医でもさくさく実践できるよう工夫し記載。そしてさまざまな症例の診療を呈示し具体的表現で理解を深め，実地の場で眼科医が役立つ構成にしている。

目次

  • 知っているようで知らない　新しい糖尿病網膜症診療

    ―目次―

    1.診療前に基礎知識を知っておこう
    　疫学　こんなに多い糖尿病網膜症(DR)！
    　原因疾患である糖尿病(DM)そのものを知ろう！
    　糖尿病網膜症(DR)の理解に必要な網膜の解剖・生理
    　糖尿病網膜症(DR)でみられる所見　一挙公開！
    　糖尿病網膜症(DR)における血管障害の原因を知っておこう！
    　糖尿病網膜症(DR)の分子細胞メカニズム
    　　VEGFと炎症細胞，やさしく解説
    　
    2.診断の基礎知識を知っておこう
    　病期の分類　覚えるのではなく理解しよう！
    　眼底検査，超広角眼底検査の進め方，診るポイント
    　蛍光眼底造影検査の進め方，診るポイント
    　光干渉断層計(OCT)の進め方，診るポイント
    　網膜電図(ERG)の進め方，診るポイント
    　検査機器トピックスその１
    　　OCT血管造影(OCTA)
    　検査機器トピックスその２
    　　レーザースペックル・フローグラフィー(LSFG)
    　検査機器トピックスその３
    　　補償光学付き走査型レーザー検眼鏡(AO-SLO)
    　
    3.治療の基礎知識を知っておこう
    　内科的治療法とは？　そして注意すべきこととは？
    　光凝固とは？　そして注意すべきこととは？
    　硝子体手術とは？　そして注意すべきこととは？
    　VEGF阻害薬の硝子体注射とは？　そして注意すべきこととは？
    　大規模臨床試験(硝子体注射)　まとめてズバッと解説！
    　大規模臨床試験(全身投与)　まとめてズバッと解説！
    　
    4.網膜症の診療を具体的に知っておこう
    　糖尿病黄斑浮腫(DME)の局所性浮腫の原因となる
    　　毛細血管瘤(MA)への直接凝固
    　前増殖糖尿病網膜症(prePDR)　汎網膜光凝固のちょっとしたコツ
    　増殖糖尿病網膜症(PDR)　こんなに治せる硝子体手術
    　血管新生緑内障併発!　治療で注意をすべきこと
    　手術合併症　トラブルシュートの実際
    　難治例への挑戦　不屈と闘志とサージャンの憂鬱
    　手術で治す糖尿病黄斑浮腫(DME)　そのサイエンスとアート
    　薬で治す糖尿病黄斑浮腫(DME)　いろんな武器を巧みに使おう
    　レーザーで治す糖尿病黄斑浮腫(DME)
    　　これが本当のグリッドだ！
    　手厚く治す糖尿病黄斑浮腫(DME)
    　　至れり尽くせりのマネージメント

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1 診療前に基礎知識を知っておこう

P.6 掲載の参考文献
1) World Health Organization. http://www.who.int/mediacentre/factsheets/fs312/en/ (最終アクセス 2016年3月1日)
 
2) Diabetes Atlas, 7th ed, Brussels, Belgium, International Diabetes Federation, 2015. http://www.diabetesatlas.org/ (最終アクセス 2016年3月1日)
 
3) 平成24年「国民健康・栄養調査」の結果 http://www.mhlw.go.jp/stf/houdou/0000032074.html/ (最終アクセス 2016年3月1日)
 
4) Kawasaki R, et al. : Impaired glucose tolerance, but not impaired fasting glucose, is associated with retinopathy in Japanese population : the Funagata study. Diabetes Obes Metab 2008 ; 10 (6) : 514-515.
 
5) Yau JW, et al. ; Meta-Analysis for Eye Disease (META-EYE) Study Group : Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012 ; 35 (3) : 556-564.
 
6) Kawasaki R, et al. ; Japan Diabetes Complications Study Group : Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes : 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia 2011 ; 54 (9) : 2288-2294.
 
7) Wong TY, et al. : Rates of progression in diabetic retinopathy during different time periods : a systematic review and meta-analysis. Diabetes Care 2009 ; 32 (12) : 2307-2313.
PubMed

2 診断の基礎知識を知っておこう

P.69 掲載の参考文献
1) 相庭伸哉, ほか : フルオレセイン蛍光眼底造影検査における副作用の検討. 臨床眼科 2015 ; 69 : 837-840.
 
2) 河田直樹, ほか : 井上眼科病院におけるフルオレセイン蛍光眼底造影での副作用. 臨床眼科 2007 ; 61 : 761-765.
 
3) 湯澤美都子, ほか ; 眼底血管造影実施基準委員会 : 眼底血管造影実施基準 (改訂版). 日本眼科学会雑誌 2011 ; 115 : 67-75.
 
4) Bregu M, et al : Nausea and fluourescein injection speed. Ophthalmology 2012 ; 119 : 1281-1281.e1281, doi : 10.1016/j.ophtha.2011.12.021.
 
5) 高野守人, ほか : 少量フルオレセインによるSLO蛍光眼底造影. 臨床眼科 1994 ; 48 : 199-204.
 
6) Silva PS, et al : Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography. Ophthalmology 2015 ; 122 : 2465-2472, doi : 10.1016/j.ophtha.2015.07.034.
 
P.98 掲載の参考文献
1) Yanagida K, et al. : Sex-related differences in ocular blood flow of healthy subjects using laser speckle flowgraphy. Invest Ophthalmol Vis Sci 2015 ; 56 : 4880-4890.
PubMed
2) Shiba T, et al. : Pulse-wave analysis of optic nerve head circulation is significantly correlated with brachial-ankle pulse-wave velocity, carotid intima-media thickness, and age. Graefes Arch Clin Exp Ophthalmol 2012 ; 250 : 1275-1281.
PubMed
3) Rina M, et al. : Pulse waveform analysis of optic nerve head circulation for predicting carotid atherosclerotic changes. Graefes Arch Clin Exp Ophthalmol 2015 ; 253 : 2285-2291.
PubMed
4) Nagaoka T, et al. : Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol 2004 ; 88 : 1060-1063.
PubMed
5) Okamoto M, et al. : EFFECTS OF PANRETINAL PHOTOCOAGULATION ON CHOROIDAL THICKNESS AND CHOROIDAL BLOOD FLOW IN PATIENTS WITH SEVERE NONPROLIFERATIVE DIABETIC RETINOPATHY. Retina 2016 ; 36 (4) : 805-811.
PubMed

3 治療の基礎知識を知っておこう

P.110 掲載の参考文献
1) The Diabetes Control and Complications Trial Research Group : The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 ; 329 : 977-986.
 
2) Ohkubo Y, et al. : Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study. Diabetes Res Clin Pract 1995 ; 28 : 103-117.
PubMed
3) UK Prospective Diabetes Study (UKPDS) Group : Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 ; 352 : 837-853.
 
4) Aiello LP, et al. ; DCCT/EDIC Research Group : Intensive diabetes therapy and ocular surgery in type 1 diabetes. N Engl J Med 2015 ; 372 : 1722-1733.
 
5) Chaturvedi N, et al. ; DIRECT Programme Study Group : Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes : randomised, placebo-controlled trials. Lancet 2008 ; 372 : 1394-1402.
 
6) Sjolie AK, et al. ; DIRECT Programme Study Group : Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2) : a randomised placebo-controlled trial. Lancet 2008 ; 372 : 1385-1393.
 
7) Keech AC, et al. : Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study) : a randomised controlled trial. Lancet 2007 ; 370 : 1687-1697.
PubMed
8) Omae T, et al. : Fenofibrate, an anti-dyslipidemia drug, elicits the dilation of isolated porcine retinal arterioles : role of nitric oxide and AMP-activated protein kinase. Invest Ophthalmol Vis Sci 2012 ; 53 : 2880-2886.
PubMed
9) The ACCORD Study Group and ACCORD Eye Study Group : Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010 ; 363 : 233-244.
 
10) 石羽澤明弘, ほか : 腎移植または血液透析導入を契機に糖尿病黄斑浮腫が改善した5症例. あたらしい眼科 2015 ; 32 (2) : 279-285.
 
11) Gupta A, et al. : Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol 2004 ; 137 : 675-682.
PubMed
12) Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998 ; 116 : 874-886.
PubMed
13) Omae T, et al. : Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, induces dilation of isolated porcine retinal arterioles : role of nitric oxide and potassium channels. Invest Ophthalmol Vis Sci 2011 ; 52 : 6749-6756.
 
14) Shen LQ, et al. : Rosiglitazone and delayed onset of proliferative diabetic retinopathy. Arch Ophthalmol 2008 ; 126 : 793-799.
PubMed
15) Fong DS, et al. : Glitazone use associated with diabetic macular edema. Am J Ophthalmol 2009 ; 147 : 583-586.
PubMed
16) 星川有子, ほか : ピオグリタゾン塩酸塩製剤の糖尿病黄斑浮腫に対する短期的影響の検討. 日眼会誌 2013 ; 117 : 357-363.
 
P.125 掲載の参考文献
1) Smiddy WE, et al. : Vitrectomy in the management of diabetic retinopathy. Surv Ophthalmol 1999 ; 43 : 491-507.
PubMed
2) Lewis H, et al. : Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992 ; 99 : 753-759.
PubMed
3) Sawa H, et al. : Neovascularization from scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy. Jpn J Ophthalmol 2000 ; 44 : 154-160.
PubMed
4) Yokota R, et al. : Comparison of microincision vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy. Jpn J Ophthalmol 2015 ; 59 : 288-294.
PubMed
P.147 掲載の参考文献
1. ACCORD Study Group ; ACCORD Eye Study Group, Chew EY, et al. : Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010 ; 363 : 233-244.
 
2) Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes : UKPDS 39. UK Prospective Diabetes Study Group. BMJ 1998 ; 317 : 713-720.
Medical*Online
3) Keech AC, et al. ; FIELD study investigators : Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study) : a randomised controlled trial. Lancet 2007 ; 370 : 1687-1697.
 
4) Gupta A, et al. : Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol 2004 ; 137 : 675-682.
PubMed
5) Nagai N, et al. : Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest Ophthalmol Vis Sci 2007 ; 48 : 4342-4350.
PubMed
6) Satofuka S, et al. : (Pro) renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes 2009 ; 58 : 1625-1633.
PubMed
7) Satofuka S, et al. : Receptor-associated prorenin system in the pathogenesis of retinal diseases. Front Biosci (Schol Ed) 2012 ; 4 : 1449-1460.
PubMed
8) Kanda A, et al. : (Pro) renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy. Diabetologia 2012 ; 55 : 3104-3113.
PubMed
9) Kanda A, et al. : Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 2013 ; 97 : 666-668.
PubMed
10) Chaturvedi N, et al. : Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998 ; 351 : 28-31.
 
11) Chaturvedi N, et al. : Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes : randomised, placebo-controlled trials. Lancet 2008 ; 372 : 1394-1402.
 
12) Sjolie AK, et al. : Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2) : a randomised placebo-controlled trial. Lancet 2008 ; 372 : 1385-1393.
PubMed
13) Mauer M, et al. : Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 2009 ; 361 : 40-51.
PubMed
14) PKC-DRS2 Group, Aiello LP, et al. : Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology 2006 ; 113 : 2221-2230.
PubMed
15) Bolton WK, et al. ; ACTION I Investigator Group : Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol 2004 ; 24 : 32-40.
PubMed
16) Hotta N, et al. : Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy : the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care 2006 ; 29 : 1538-1544.
PubMed
17) Shen LQ, et al : Rosiglitazone and delayed onset of proliferative diabetic retinopathy. Arch Ophthalmol 2008 ; 126 : 793-799.
PubMed
18) Early Treatment Diabetic Retinopathy Study Research Group : Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Ophthalmology 1991 ; 98 : 757-765.
 

4 網膜症の診療を具体的に知っておこう

P.160 掲載の参考文献
1) Early Treatment Diabetic Retinopathy Study research group : Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985 ; 103 : 1796-1806.
 
2) Liegl R, et al. : Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema. PLoS One 2014 ; 9 : e113981.
PubMed
3) Hirano Y, et al. : Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia. Br J Ophthalmol 2010 ; 94 : 600-605.
 
4) Ogura S, et al. : Indocyanine Green Angiography-Guided Focal Laser Photocoagulation for Diabetic Macular Edema. Ophthalmologica 2015 ; 234 : 139-150.
PubMed
P.196 掲載の参考文献
1) Weiss DI, et al. : Neovascular glaucoma complicating carotid-cavernous fistula. Arch Ophthalmol 1963 ; 69 : 304.
PubMed
2) Kim M, et al. : Angiogenesis in glaucoma filtration surgery and neovascular glaucoma : A review. Surv Ophthalmol 2015 ; 60 : 524-535.
PubMed
3) Uram M : Ophthalmic laser microendoscope ciliary process ablation in the management of neovascular glaucoma. Ophthalmology 1992 ; 99 : 1823-1828.
PubMed
4) Takihara Y, et al. : Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma. J Glaucoma 2011 ; 20 : 196-201.
PubMed
5) Shen CC, et al. : Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma. Clin Ophthalmol 2011 ; 5 : 281-286.
PubMed
6) Budenz DL, et al. ; Ahmed Baerveldt Comparison Study Group : Postoperative Complications in the Ahmed Baerveldt Comparison Study During Five Years of Follow-up. Am J Ophthalmol 2016 ; 163 : 75-82.
 
P.239 掲載の参考文献
1) Early Treatment Diabetic Retinopathy Study research group : Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985 ; 103 : 1796-1806.
 
2) Schatz H, et al. : Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 1991 ; 109 : 1549-1551.
PubMed
3) Arup D, et al. : Diabetic macular edema : Pathophysiology and novel therapeutic target. Ophthalmology 2015 ; 122 : 1375-1394.
 
4) Blumenkranz MS, et al. : Semiautomated patterned scanning laser for retinal photocoagulation. Retina 2006 ; 26 : 370-376.
PubMed
5) Fong DS, et al. : Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 2007 ; 125 : 469-480.
PubMed
6) Makita S, et al. : Optical coherence angiography. Opt Express 2006 ; 14 : 7821-7840.
PubMed

書評

最近チェックした商品履歴

Loading...